Global Antidiabetic Drugs Market Professional Survey Report 2017

October 2017 | 104 pages | ID: GEB8D1AEDBAPEN
QYResearch

Abstracts

This report studies Antidiabetic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Eli Lilly
• Novartis
• Boehringer Ingelheim
• Merck
• Novo Nordisk
• Sanofi
• AstraZeneca
• Takeda
• Bayer
• Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral Drugs
• Injectable Drugs

By Application, the market can be split into

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes Mellitus
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Antidiabetic Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ANTIDIABETIC DRUGS

1.1 Definition and Specifications of Antidiabetic Drugs
  1.1.1 Definition of Antidiabetic Drugs
  1.1.2 Specifications of Antidiabetic Drugs
1.2 Classification of Antidiabetic Drugs
  1.2.1 Oral Drugs
  1.2.2 Injectable Drugs
1.3 Applications of Antidiabetic Drugs
  1.3.1 Type 1 Diabetes
  1.3.2 Type 2 Diabetes
  1.3.3 Gestational Diabetes Mellitus
  1.3.4 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTIDIABETIC DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antidiabetic Drugs
2.3 Manufacturing Process Analysis of Antidiabetic Drugs
2.4 Industry Chain Structure of Antidiabetic Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTIDIABETIC DRUGS

3.1 Capacity and Commercial Production Date of Global Antidiabetic Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Antidiabetic Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Antidiabetic Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Antidiabetic Drugs Major Manufacturers in 2016

4 GLOBAL ANTIDIABETIC DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Antidiabetic Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Antidiabetic Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Antidiabetic Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Antidiabetic Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Antidiabetic Drugs Sales Price
  4.4.2 2016 Antidiabetic Drugs Sales Price Analysis (Company Segment)

5 ANTIDIABETIC DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Antidiabetic Drugs Market Analysis
  5.1.1 North America Antidiabetic Drugs Market Overview
  5.1.2 North America 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.1.4 North America 2016 Antidiabetic Drugs Market Share Analysis
5.2 China Antidiabetic Drugs Market Analysis
  5.2.1 China Antidiabetic Drugs Market Overview
  5.2.2 China 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.2.4 China 2016 Antidiabetic Drugs Market Share Analysis
5.3 Europe Antidiabetic Drugs Market Analysis
  5.3.1 Europe Antidiabetic Drugs Market Overview
  5.3.2 Europe 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.3.4 Europe 2016 Antidiabetic Drugs Market Share Analysis
5.4 Southeast Asia Antidiabetic Drugs Market Analysis
  5.4.1 Southeast Asia Antidiabetic Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Antidiabetic Drugs Market Share Analysis
5.5 Japan Antidiabetic Drugs Market Analysis
  5.5.1 Japan Antidiabetic Drugs Market Overview
  5.5.2 Japan 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.5.4 Japan 2016 Antidiabetic Drugs Market Share Analysis
5.6 India Antidiabetic Drugs Market Analysis
  5.6.1 India Antidiabetic Drugs Market Overview
  5.6.2 India 2012-2017E Antidiabetic Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Antidiabetic Drugs Sales Price Analysis
  5.6.4 India 2016 Antidiabetic Drugs Market Share Analysis

6 GLOBAL 2012-2017E ANTIDIABETIC DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Antidiabetic Drugs Sales by Type
6.2 Different Types of Antidiabetic Drugs Product Interview Price Analysis
6.3 Different Types of Antidiabetic Drugs Product Driving Factors Analysis
  6.3.1 Oral Drugs of Antidiabetic Drugs Growth Driving Factor Analysis
  6.3.2 Injectable Drugs of Antidiabetic Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ANTIDIABETIC DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Antidiabetic Drugs Consumption by Application
7.2 Different Application of Antidiabetic Drugs Product Interview Price Analysis
7.3 Different Application of Antidiabetic Drugs Product Driving Factors Analysis
  7.3.1 Type 1 Diabetes of Antidiabetic Drugs Growth Driving Factor Analysis
  7.3.2 Type 2 Diabetes of Antidiabetic Drugs Growth Driving Factor Analysis
  7.3.3 Gestational Diabetes Mellitus of Antidiabetic Drugs Growth Driving Factor Analysis
  7.3.4 Others of Antidiabetic Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTIDIABETIC DRUGS

8.1 Eli Lilly
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Eli Lilly 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Eli Lilly 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.2 Novartis
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Novartis 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Novartis 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.3 Boehringer Ingelheim
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Boehringer Ingelheim 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Boehringer Ingelheim 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.4 Merck
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Merck 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Merck 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.5 Novo Nordisk
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Novo Nordisk 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Novo Nordisk 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.6 Sanofi
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.7 AstraZeneca
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 AstraZeneca 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 AstraZeneca 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.8 Takeda
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Takeda 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Takeda 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.9 Bayer
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Bayer 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Bayer 2016 Antidiabetic Drugs Business Region Distribution Analysis
8.10 Pfizer
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Pfizer 2016 Antidiabetic Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Pfizer 2016 Antidiabetic Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ANTIDIABETIC DRUGS MARKET

9.1 Global Antidiabetic Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Antidiabetic Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Antidiabetic Drugs Sales Price Forecast
9.2 Antidiabetic Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Antidiabetic Drugs Consumption Forecast
  9.2.2 China 2017-2022 Antidiabetic Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Antidiabetic Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Antidiabetic Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Antidiabetic Drugs Consumption Forecast
  9.2.6 India 2017-2022 Antidiabetic Drugs Consumption Forecast
9.3 Antidiabetic Drugs Market Trend (Product Type)
9.4 Antidiabetic Drugs Market Trend (Application)

10 ANTIDIABETIC DRUGS MARKETING TYPE ANALYSIS

10.1 Antidiabetic Drugs Regional Marketing Type Analysis
10.2 Antidiabetic Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antidiabetic Drugs by Region
10.4 Antidiabetic Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTIDIABETIC DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTIDIABETIC DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Drugs
Table Product Specifications of Antidiabetic Drugs
Table Classification of Antidiabetic Drugs
Figure Global Production Market Share of Antidiabetic Drugs by Type in 2016
Figure Oral Drugs Picture
Table Major Manufacturers of Oral Drugs
Figure Injectable Drugs Picture
Table Major Manufacturers of Injectable Drugs
Table Applications of Antidiabetic Drugs
Figure Global Consumption Volume Market Share of Antidiabetic Drugs by Application in 2016
Figure Type 1 Diabetes Examples
Table Major Consumers in Type 1 Diabetes
Figure Type 2 Diabetes Examples
Table Major Consumers in Type 2 Diabetes
Figure Gestational Diabetes Mellitus Examples
Table Major Consumers in Gestational Diabetes Mellitus
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Antidiabetic Drugs by Regions
Figure North America Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure China Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Europe Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure Japan Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Figure India Antidiabetic Drugs Market Size (Million USD) (2012-2022)
Table Antidiabetic Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antidiabetic Drugs in 2016
Figure Manufacturing Process Analysis of Antidiabetic Drugs
Figure Industry Chain Structure of Antidiabetic Drugs
Table Capacity and Commercial Production Date of Global Antidiabetic Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Antidiabetic Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Antidiabetic Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Antidiabetic Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Antidiabetic Drugs 2012-2017
Figure Global 2012-2017E Antidiabetic Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Antidiabetic Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Antidiabetic Drugs Capacity and Growth Rate
Table 2016 Global Antidiabetic Drugs Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Antidiabetic Drugs Sales (K Pcs) and Growth Rate
Table 2016 Global Antidiabetic Drugs Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Antidiabetic Drugs Sales Price (USD/Pcs)
Table 2016 Global Antidiabetic Drugs Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure North America 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure North America 2016 Antidiabetic Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure China 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure China 2016 Antidiabetic Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure Europe 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure Europe 2016 Antidiabetic Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Antidiabetic Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure Japan 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure Japan 2016 Antidiabetic Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Drugs 2012-2017E
Figure India 2012-2017E Antidiabetic Drugs Sales Price (USD/Pcs)
Figure India 2016 Antidiabetic Drugs Sales Market Share
Table Global 2012-2017E Antidiabetic Drugs Sales (K Pcs) by Type
Table Different Types Antidiabetic Drugs Product Interview Price
Table Global 2012-2017E Antidiabetic Drugs Sales (K Pcs) by Application
Table Different Application Antidiabetic Drugs Product Interview Price
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eli Lilly Antidiabetic Drugs Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis Antidiabetic Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2015 Boehringer Ingelheim Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Boehringer Ingelheim Antidiabetic Drugs Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck Antidiabetic Drugs Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novo Nordisk Antidiabetic Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Sanofi Antidiabetic Drugs Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Antidiabetic Drugs Business Region Distribution
Table Takeda Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Takeda Antidiabetic Drugs Business Region Distribution
Table Bayer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer Antidiabetic Drugs Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Antidiabetic Drugs Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Pfizer Antidiabetic Drugs Business Region Distribution
Figure Global 2017-2022 Antidiabetic Drugs Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Antidiabetic Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Antidiabetic Drugs Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Antidiabetic Drugs Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Antidiabetic Drugs by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Antidiabetic Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Antidiabetic Drugs by Region